Tele-Clinic Visits in Pediatric Marfan Patients Using Parental Echo: The Future?

• ClinicalTrials.gov Identifier: NCT03581682
• Recruitment Status: Completed
• First Posted: July 10, 2018
• Last Update Posted: March 17, 2021
• Sponsor: Stanford University
• Information provided by (Responsible Party): Seda Tierney, Stanford University

Study Description

Brief Summary:

Marfan syndrome (MFS), a connective tissue disorder seen in 1 in 3,000 individuals, causes progressive aortic root dilation that can result in aortic dissection and sudden death. Clinical care focuses on monitoring the aortic root by serial echocardiography (echo) to guide medical treatment and elective aortic root surgery in a specialized clinic every 6-12 months. This monitoring protocol, coupled with surgical intervention, has doubled the median life expectancy which was previously only 32 years. However, this surveillance carries significant health care costs at >$50 million dollars/year on echos alone (at $3-4K each) in children and adolescents in the US, as well as substantial burden on families residing far from specialized centers. A clinic visit delivered to MFS patients via live-video conferencing at home (tele-visit) could shift this paradigm, if a home echo could be obtained.

Here, the investigator will train parents of Pediatric Marfan patients to take echo images using a hand held device, height, weight, blood pressure, medical history, and listen to the heart of their child. Then, the investigators will ask them to take the equipment home and collect the same data at home during a tele-clinic visit, with further instruction by the study team through secure live-video conferencing.

Condition or disease	Intervention/treatment	Phase
Marfan Syndrome	Other: Tele-Clinic Visits Using Parent-Acquired Echos	Not Applicable

Detailed Description:

In the proposed intervention, every patient (n=60) will have a tele-visit and an on-site clinic visit 1 day apart. Parents will have a 1-hour hands-on training session to acquire basic echo images on their children with the same hand-held device that will be used during the tele-visit. Tele-visit elements will include interim medical history by the parent and patient, and weight, height, vital signs, digital cardiac auscultation, and home echo (transferred via Internet for remote interpretation), all obtained by the parent. Two MFS physicians, following our routine MFS care protocol, will administer either the tele-visit or on-site clinic visit, masked to the findings of the other. Two independent echo readers will analyze home and clinic echos to measure reproducibility.

Study Design

• Study Type: Interventional (Clinical Trial)
• Actual Enrollment: 15 participants
• Allocation: N/A
• Intervention Model: Single Group Assignment
• Masking: None (Open Label)
• Primary Purpose: Other
• Official Title: Tele-Clinic Visits in Pediatric Marfan Patients Using Parental Echo: The Future?
• Actual Study Start Date: July 1, 2018
• Actual Primary Completion Date: August 1, 2020
• Actual Study Completion Date: August 1, 2020

Arms and Interventions

Arm

Intervention/treatment

Experimental: Tele-Visit Using Parental Home Echo; All parents will have hands-on echo training. We will test if a tele-visit using parental home echo is clinically reliable compared to an on-site clinic visit, costs less, and improves parental sense of empowerment.

Other: Tele-Clinic Visits Using Parent-Acquired Echos; Every patient will have a tele-visit and an on-site clinic visit 1 day apart 3-6 months after the training session. Parents will have a 1-hour hands-on training session to acquire basic echo images on their children with the same hand-held device that they will use during the tele-visit. The parents will also have an in-service on how to take weight, height, and blood pressure measurements, and how to use the digital stethoscope. A tele-visit will be schedule a day prior to the patient's regularly scheduled clinic visit. Tele-visit elements will include interim medical history by the parent and patient, and weight, height, vital signs, digital cardiac auscultation, and home echo, all obtained by the parent. Two MFS physicians, following our routine MFS care protocol, will administer either the tele-visit or on-site clinic visit, masked to the findings of the other.

Outcome Measures

Primary Outcome Measures :

1. Percent of tele-visits with a clinical visit match-score of ≥13/15 points [ Time Frame: 3-6 months ]
   This scoring system was determined after surveying pediatric MFS physicians nationwide and includes these sections: Echo, vital signs, height and weight, interim medical history, cardiac auscultation, and determination of follow up time and medication dose/type.

Secondary Outcome Measures :

1. To test if a tele-visit using parental home echo costs less than an on-site clinic visit. [ Time Frame: 3-6 months ]

   The outcome will be the costs of tele-visit and clinic visit. Two cost components will be estimated and combined costs will be compared: (1) Payer cost: Actual cost to deliver a tele-visit with home echo (as it is not currently covered by insurance) vs.

   Medical or private insurance reimbursement rates for clinic visit with an echo; and (2) Patient-cost: time and travel costs for parents.

2. To test if a tele-visit using parental home echo costs less than an on-site clinic visit. [ Time Frame: 3-6 months ]
   Secondary outcome will be lost school time for the patient.
3. To determine if this intervention increases parental sense of empowerment. [ Time Frame: 3-6 months ]
   The outcome will be the change in Family Empowerment Score (a validated questionnaire to assess empowerment in parents of children with illness) from study start to study end.
4. To determine if this intervention increases parental sense of empowerment. [ Time Frame: 3-6 months ]
   Secondary outcomes will be parent/patient satisfaction survey results for televisits and clinic visits using the CAHPS survey for Children, as well as patient, parent and physician interviews.

Eligibility Criteria

• Ages Eligible for Study: 5 Years to 19 Years (Child, Adult)
• Sexes Eligible for Study: All
• Accepts Healthy Volunteers: No

Criteria

Inclusion Criteria:

• 5-19 years of age (patient)
• seen in at least 2 prior clinic visits
• Marfan syndrome by revised Ghent criteria
• presence of parent at home

Exclusion Criteria:

• prior aortic surgery
• known cardiomyopathy
• known arrhythmia
• aortic root > 4.5 cm in prior clinic visit
• pregnancy

Contacts and Locations

Locations

United States, California

Lucile Packard Children's Hospital

Palo Alto, California, United States, 94304

Sponsors and Collaborators

Stanford University

Investigators

• Principal Investigator: Seda Tierney, MD; Stanford University

More Information

Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):

Chen A, Punn R, Collins RT, Chen JH, Stauffer KJ, Wang R, Alexander S, MacMillen Lechich K, Murphy DJ, Chung S, Selamet Tierney ES. Tele-Clinic Visits in Pediatric Patients with Marfan Syndrome Using Parentally Acquired Echocardiography. J Pediatr. 2021 May;232:140-146. doi: 10.1016/j.jpeds.2021.01.004. Epub 2021 Jan 13.

• Responsible Party: Seda Tierney, Associate Professor of Pediatrics, Stanford University
• ClinicalTrials.gov Identifier: NCT03581682
• Other Study ID Numbers: 42159
• First Posted: July 10, 2018
• Last Update Posted: March 17, 2021
• Last Verified: March 2021

Individual Participant Data (IPD) Sharing Statement:

• Plan to Share IPD: Undecided

• Studies a U.S. FDA-regulated Drug Product: No
• Studies a U.S. FDA-regulated Device Product: No

Additional relevant MeSH terms:

Marfan Syndrome; Arachnodactyly; Bone Diseases, Developmental; Bone Diseases; Musculoskeletal Diseases; Heart Defects, Congenital; Cardiovascular Abnormalities; Cardiovascular Diseases; Heart Diseases; Abnormalities, Multiple; Congenital Abnormalities; Genetic Diseases, Inborn; Connective Tissue Diseases; Limb Deformities, Congenital; Musculoskeletal Abnormalities